BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22285135)

  • 1. [Treatment of chronic kidney disease: therapeutic strategy].
    Belenfant X; Tabbi Anani W; Roland M; Mavel MC; Laederich J
    Presse Med; 2012 Mar; 41(3 Pt 1):304-10. PubMed ID: 22285135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic kidney disease: therapy and care].
    Noel N; Gaha K; Rieu P
    Rev Prat; 2012 Jan; 62(1):43-51. PubMed ID: 22335066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the management of chronic kidney disease.
    Rivera JA; O'Hare AM; Harper GM
    Am Fam Physician; 2012 Oct; 86(8):749-54. PubMed ID: 23062158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowing the progression of chronic kidney disease.
    Herrington WG; Mason PD
    Br J Hosp Med (Lond); 2009 Nov; 70(11):634-8. PubMed ID: 20081590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consensus document for the detection and management of chronic kidney disease].
    Martínez-Castelao A; Górriz JL; Bover J; Segura-de la Morena J; Cebollada J; Escalada J; Esmatjes E; Fácila L; Gamarra J; Gràcia S; Hernández-Moreno J; Llisterri-Caro JL; Mazón P; Montañés R; Morales-Olivas F; Muñoz-Torres M; de Pablos-Velasco P; de Santiago A; Sánchez-Celaya M; Suárez C; Tranche S
    Endocrinol Nutr; 2014 Nov; 61(9):e25-43. PubMed ID: 25171835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia].
    Hannedouche T; Fouque D; Joly D
    Nephrol Ther; 2018 Nov; 14(6S):6S17-6S25. PubMed ID: 30473062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Remission Clinic approach to halt the progression of kidney disease.
    ;
    J Nephrol; 2011; 24(3):274-81. PubMed ID: 21534237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the management of chronic kidney disease in Uruguay: a National Renal Healthcare Program.
    Schwedt E; Solá L; Ríos PG; Mazzuchi N;
    Nephron Clin Pract; 2010; 114(1):c47-59. PubMed ID: 19816043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MAURO study: baseline characteristics and compliance with guidelines targets.
    Leonardis D; Mallamaci F; Enia G; Postorino M; Tripepi G; Zoccali C;
    J Nephrol; 2012; 25(6):1081-90. PubMed ID: 23172127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrology Update: Chronic Kidney Disease.
    Saha S; Rahman M
    FP Essent; 2016 May; 444():18-22. PubMed ID: 27163761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of CKD and its prevention.
    Amaresan MS; Geetha R
    J Assoc Physicians India; 2008 Jan; 56():41-6. PubMed ID: 18472500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing blood pressure control in patients with nondiabetic glomerular disease.
    Umanath K; Lewis JB; Dwyer JP
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):200-4. PubMed ID: 24602469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
    Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets.
    Lam A; Shah S; Paparello J
    Dis Mon; 2010 Apr; 56(4):215-32. PubMed ID: 20350654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme.
    Soares CM; Diniz JS; Lima EM; Oliveira GR; Canhestro MR; Colosimo EA; Simoes e Silva AC; Oliveira EA
    Nephrol Dial Transplant; 2009 Mar; 24(3):848-55. PubMed ID: 18840891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.